検索
NuCana PLC
NCNAウォッチリストに追加
1.130USD
-0.010-0.88%
終値 10-08 16:00（ET）
4.70M時価総額
0.02直近12ヶ月PER
NuCana PLCについて 企業名
NuCana plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is focused on developing treatment outcomes for patients with cancer by applying its ProTide technology. The Company's pipeline includes NUC-7738 and NUC-3373. NUC-7738 is an anti-cancer agent that disrupts Ribonucleic acid (RNA) polyadenylation, profoundly impacts gene expression in cancer cells and targets multiple aspects of the tumor microenvironment. NUC-7738 is in the Phase II part of a Phase I/II study which is evaluating NUC-7738 as a monotherapy in patients with advanced solid tumors and in combination with pembrolizumab in patients with melanoma. NUC-3373 is a chemical entity derived from the nucleoside analog 5-fluorouracil, a chemotherapy agent. NUC-3373 is being evaluated in a Phase Ib/II modular study (NuTide:303) of NUC-3373 in combination with the PD-1 inhibitor pembrolizumab for patients with advanced solid tumors and in combination with docetaxel for patients with lung cancer.
NuCana PLC プロフィール
企業コードNCNA
会社名NuCana PLC
上場日Sep 28, 2017
最高経営責任者「CEO」- -
従業員数20
証券種類Depository Receipt
決算期末Sep 28
本社所在地Lochside House
都市EDINBURGH
証券取引所NASDAQ OMX - NASDAQ BASIC
国United Kingdom
郵便番号EH12 9DT
電話番号4401313571111
ウェブサイトhttps://www.nucana.com/
企業コードNCNA
上場日Sep 28, 2017
最高経営責任者「CEO」- -
NuCana PLCの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Hugh S. Griffith
Mr. Hugh S. Griffith
Chief Executive Officer, Co-Founder, Executive Director
Chief Executive Officer, Co-Founder, Executive Director
53.00
--
Mr. Hugh S. Griffith
Mr. Hugh S. Griffith
Chief Executive Officer, Co-Founder, Executive Director
Chief Executive Officer, Co-Founder, Executive Director
53.00
--
Mr. Martin Mellish
Mr. Martin Mellish
Non-Executive Independent Director
Non-Executive Independent Director
7.00
--
Mr. Martin Mellish
Mr. Martin Mellish
Non-Executive Independent Director
Non-Executive Independent Director
7.00
--
Dr. Elliott M. Levy, M.D.
Dr. Elliott M. Levy, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
4.00
--
Dr. Elliott M. Levy, M.D.
Dr. Elliott M. Levy, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
4.00
--
Dr. Cyrille Leperlier, M.D.
Dr. Cyrille Leperlier, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Bali Muralidhar, M.D., Ph.D.
Dr. Bali Muralidhar, M.D., Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Andrew Kay
Mr. Andrew Kay
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Christopher F. Brinzey
Mr. Christopher F. Brinzey
Investor Relations
Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Hugh S. Griffith
Mr. Hugh S. Griffith
Chief Executive Officer, Co-Founder, Executive Director
Chief Executive Officer, Co-Founder, Executive Director
53.00
--
Mr. Hugh S. Griffith
Mr. Hugh S. Griffith
Chief Executive Officer, Co-Founder, Executive Director
Chief Executive Officer, Co-Founder, Executive Director
53.00
--
Mr. Martin Mellish
Mr. Martin Mellish
Non-Executive Independent Director
Non-Executive Independent Director
7.00
--
Mr. Martin Mellish
Mr. Martin Mellish
Non-Executive Independent Director
Non-Executive Independent Director
7.00
--
Dr. Elliott M. Levy, M.D.
Dr. Elliott M. Levy, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
4.00
--
Dr. Elliott M. Levy, M.D.
Dr. Elliott M. Levy, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
4.00
--
よくある質問
NuCana PLCの上位5名の株主は誰ですか？
NuCana PLCの上位5名の株主は以下のとおりです。Mr. Hugh S. Griffith
NuCana PLC（NCNA）の株式を保有している機関の数はいくつですか？
2026Q1時点で、NuCana PLCの株式を保有している機関は46社あり、保有株式の総市場価値は約32.77Kで、全体の0.79%を占めています。2025Q4と比較して、機関の持ち株は-151989.00増加しています。